Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Aug. 01, 2015	Aug. 02, 2014
Cash flows from operating activities:
Net income	$ 600,573	$ 520,625
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	97,459	83,147
Amortization of intangibles	73,791	1,720
Stock-based compensation expense	52,836	35,419
Excess tax benefit-stock options	(22,150)	(21,349)
Deferred income taxes	(26,564)	(8,305)
Other non-cash activity	9,402	3,823
Changes in operating assets and liabilities	(75,524)	(5,741)
Total adjustments	109,250	88,714
Net cash provided by operating activities	709,823	609,339
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(4,275,797)	(5,539,018)
Maturities of short-term available-for-sale investments	2,939,035	5,810,937
Sales of short-term available-for-sale investments	1,091,648	1,700,130
Additions to property, plant and equipment	(108,153)	(134,496)
Payments for acquisitions, net of cash acquired	(7,065)	(1,943,704)
Increase in other assets	(9,377)	(9,422)
Net cash used for investing activities	(369,709)	(115,573)
Cash flows from financing activities:
Proceeds from debt	0	1,995,398
Dividend payments to shareholders	(365,477)	(337,917)
Repurchase of common stock	(115,251)	(168,971)
Proceeds from employee stock plans	114,871	178,581
Contingent consideration payment	(1,767)	(3,576)
Changes in other financing activities	(3,224)	16,370
Excess tax benefit-stock options	22,150	21,349
Net cash (used for) provided by financing activities	(348,698)	1,701,234
Effect of exchange rate changes on cash	(3,152)	(1,648)
Net (decrease) increase in cash and cash equivalents	(11,736)	2,193,352
Cash and cash equivalents at beginning of period	569,233	392,089
Cash and cash equivalents at end of period	$ 557,497	$ 2,585,441